Dow Down 0.25% Nasdaq Down 0.26%

Insmed Incorporated (INSM)

-NasdaqGS
13.82 Down 0.12(0.86%) Aug 28, 4:00PM EDT
Prev Close:13.94
Open:13.87
Bid:12.15 x 300
Ask:14.50 x 1500
1y Target Est:32.20
Beta:0.21
Next Earnings Date:N/A
Day's Range:13.64 - 14.10
52wk Range:11.25 - 22.29
Volume:700,417
Avg Vol (3m):985,194
Market Cap:542.89M
P/E (ttm):N/A
EPS (ttm):-1.54
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
INSMDown 0.86%542.89M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.86
Quarterly EPS Est (Sep-14) :-0.48
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Insmed Incorporated, a biopharmaceutical company, focuses on developing and commercializing inhaled therapies for patients with serious lung diseases. Its lead product candidate is ARIKAYCE, an inhaled antibiotic treatment that delivers a proven a... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback